IL-6/JAK/STAT3 signaling in breast cancer metastasis: biology and treatment

SG Manore, DL Doheny, GL Wong, HW Lo - Frontiers in oncology, 2022 - frontiersin.org
Breast cancer is the most commonly diagnosed cancer in women. Metastasis is the primary
cause of mortality for breast cancer patients. Multiple mechanisms underlie breast cancer …

Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted …

M Liao, R Qin, W Huang, HP Zhu, F Peng… - Journal of Hematology & …, 2022 - Springer
Triple-negative breast cancer (TNBC) is a subtype of human breast cancer with one of the
worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell …

STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges

GL Wong, SG Manore, DL Doheny, HW Lo - Seminars in cancer biology, 2022 - Elsevier
Breast cancer is the most commonly diagnosed cancer and second-leading cause of cancer
deaths in women. Breast cancer stem cells (BCSCs) promote metastasis and therapeutic …

Role of STAT3 in the initiation, progression, proliferation and metastasis of breast cancer and strategies to deliver JAK and STAT3 inhibitors

YH Dinakar, H Kumar, SL Mudavath, R Jain, R Ajmeer… - Life Sciences, 2022 - Elsevier
Introduction Breast cancer (BC) accounts for the majority of cancers among the female
population. Anomalous activation of various signaling pathways has become an issue of …

STAT3 signaling in breast cancer: multicellular actions and therapeutic potential

SQ To, RS Dmello, AK Richards, M Ernst, AL Chand - Cancers, 2022 - mdpi.com
Simple Summary Many signaling pathways are overactive in breast cancer, and among
them is the STAT3 signaling pathway. STAT3 is activated by secreted factors within the …

c-Kit induces migration of triple-negative breast cancer cells and is a promising target for tyrosine kinase inhibitor treatment

JA López-Mejía, LF Tallabs-Utrilla… - International Journal of …, 2022 - mdpi.com
Triple-negative breast cancer (TNBC) is associated with a poor prognosis and the absence
of targeted therapy. c-Kit, a receptor tyrosine kinase (RTK), is considered a molecular target …

[HTML][HTML] An in vitro investigation of the apoptosis-inducing activity of corosolic acid in breast cancer cells

SA Jasim, OZ Khalaf, SH Alshahrani… - Iranian Journal of …, 2023 - ncbi.nlm.nih.gov
Objective (s): Breast cancer is the most prevalent cancer among females with different
molecular subtypes. Corosolic acid is a pentacyclic triterpenoid with anti-cancer properties …

An update on investigational therapies that target STAT3 for the treatment of cancer

M Santoni, F Miccini, A Cimadamore… - Expert opinion on …, 2021 - Taylor & Francis
Introduction Signal transducer and activator of transcription 3 (STAT3) is involved in cancer
initiation and resistance to chemo-radiation therapies and targeted agents. The role of …

Dual-responsive PEG–lipid polyester nanoparticles for siRNA and vaccine delivery elicit anti-cancer immune responses by modulating tumor microenvironment

Z Liu, L Zhao, Y Feng, Q Wang, N Dong, Y Zhang… - Biomaterials …, 2023 - pubs.rsc.org
Cancer vaccine-based immunotherapy has great potential; however, the vaccines have
been hindered by the immunosuppressive tumor microenvironment (TME). In this study, dual …

High expression of STAT3 within the tumour‐associated stroma predicts poor outcome in breast cancer patients

E Morrow, K Pennel, P Hatthakarnkul, H Leslie… - Cancer …, 2023 - Wiley Online Library
Introduction Triple‐negative breast cancer (TNBC) patients have the poorest clinical
outcomes compared to other molecular subtypes of breast cancer. IL6/JAK/STAT3 signalling …